851884-87-2

851884-87-2 structure

Name: GKA 50
Chemical Name: 6-[(3-{[(2S)-1-Methoxy-2-propanyl]oxy}-5-{[(2S)-1-phenyl-2-propan yl]oxy}benzoyl)amino]nicotinic acid
CAS Number: 851884-87-2
Molecular Formula: C₂₆H₂₈N₂O₆
Molecular Weight: 464.51000
Catalog: Signaling Pathways Metabolic Enzyme/Protease Glucokinase
Create Date: 2016-06-15 09:47:38
Modify Date: 2024-01-12 10:03:00
GKA50 is a potent glucokinase activator (EC50=33 nM at 5 mM glucose). GKA50 stimulates insulin release from mouse islets of Langerhans and MIN6 cells. GKA50 shows significant glucose lowering in high fat fed female rats[1][2].

Name	6-[(3-{[(2S)-1-Methoxy-2-propanyl]oxy}-5-{[(2S)-1-phenyl-2-propan yl]oxy}benzoyl)amino]nicotinic acid

Description	GKA50 is a potent glucokinase activator (EC50=33 nM at 5 mM glucose). GKA50 stimulates insulin release from mouse islets of Langerhans and MIN6 cells. GKA50 shows significant glucose lowering in high fat fed female rats[1][2].
Related Catalog	Signaling Pathways >> Metabolic Enzyme/Protease >> Glucokinase Research Areas >> Metabolic Disease
In Vitro	GKA50 (0.01-100 μM; 24 hours) enhances INS-1 cell proliferation with EC50values ranging from 1 to 2 μM[2]. GKA50 (1.2 μM+40 μM glucose; 2-4 days) treatment reduces apoptosis induced by chronic high glucose in INS-1 cells[2]. GKA50 activates human glucokinase enzymatic activity with an EC50 of 0.022 μM. GKA50 stimulates insulin secretion in the pancreatic insulinoma cell line, INS-1, with an EC50 of 0.065 μM. GKA50 reduces chronic-high-glucose-induced apoptosis via modulation of glucokinase and apoptotic protein BAD[2]. Cell Proliferation Assay[2] Cell Line: INS-1 cells (starved overnight with 3 μM glucose) Concentration: 0.01-100 μM Incubation Time: 24 hours Result: Stimulated cell proliferation in a dose-dependent manner, with EC50 values ranging from 1 to 2 μM.
In Vivo	GKA50 (1-30 mg/kg; p.o.) gives significant glucose lowering in an oral glucose tolerance test[1]. Animal Model: High-fat-fed obese female Zucker (fa/fa) rats[1] Dosage: 1, 3, 10, 30 mg/kg Administration: Oral administration Result: Significant percentage glucose lowering.
References	[1]. Coope GJ, et al. Predictive blood glucose lowering efficacy by Glucokinase activators in high fat fed female Zucker rats. Br J Pharmacol. 2006 Oct;149(3):328-35. [2]. McGlasson L, et al. The glucokinase activator GKA50 causes an increase in cell volume and activation of volume-regulated anion channels in rat pancreatic β-cells. Mol Cell Endocrinol. 2011 Aug 6;342(1-2):48-53.

Molecular Formula	C₂₆H₂₈N₂O₆
Molecular Weight	464.51000
Exact Mass	464.19500
PSA	110.47000
LogP	4.83980

Symbol	GHS07
Signal Word	Warning
Hazard Statements	H302-H413
Hazard Codes	Xi
RIDADR	NONH for all modes of transport

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.

851884-87-2	197903-13-2
1592908-75-2	125622-72-2
12640-54-9	55963-89-8
130930-50-6	1363154-45-3
1628543-50-9	37251-23-3
2171304-16-6	2171420-15-6
2171466-85-4	2171610-96-9
2171443-31-3	2171864-03-0
2171373-50-3	2171613-73-1
2172317-87-0	2171928-40-6